Catherine T. Doherty - Mar 3, 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Signature
Sean D. Mersten, Attorney in Fact for Catherine T. Doherty
Stock symbol
DGX
Transactions as of
Mar 3, 2025
Transactions value $
$738,665
Form type
4
Date filed
3/5/2025, 04:38 PM
Previous filing
Feb 28, 2025
Next filing
Mar 7, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Tax liability -$68.5K -394 -0.57% $173.74 68.8K Mar 3, 2025 Direct F1
transaction DGX Common Stock Sale -$126K -716 -1.04% $175.79 68.1K Mar 4, 2025 Direct F2
transaction DGX Common Stock Award $1.8M +10.4K +15.25% $173.74 78.4K Mar 4, 2025 Direct F3
transaction DGX Common Stock Tax liability -$870K -5.01K -6.39% $173.74 73.4K Mar 4, 2025 Direct F4
holding DGX Common Stock 4.43K Mar 3, 2025 401(k)/SDCP F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
F2 This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
F3 Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award approved in accordance with the requirements of Rule 16b-3(d).
F4 Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.
F5 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.